|
US3993071A
(en)
|
1971-09-09 |
1976-11-23 |
Alza Corporation |
Bioerodible ocular device
|
|
US3949750A
(en)
|
1974-10-07 |
1976-04-13 |
Freeman Jerre M |
Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
|
|
US4915684A
(en)
|
1988-06-21 |
1990-04-10 |
Mackeen Donald L |
Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus
|
|
US5469867A
(en)
|
1992-09-02 |
1995-11-28 |
Landec Corporation |
Cast-in place thermoplastic channel occluder
|
|
US6027470A
(en)
|
1998-06-10 |
2000-02-22 |
Eagle Vision, Inc. |
Punctum plug and method for inserting the same into the punctual opening
|
|
US5902598A
(en)
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
|
US6646001B2
(en)
|
1997-12-19 |
2003-11-11 |
Alcon Manufacturing, Ltd. |
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
|
|
US6196993B1
(en)
|
1998-04-20 |
2001-03-06 |
Eyelab Group, Llc |
Ophthalmic insert and method for sustained release of medication to the eye
|
|
US6632457B1
(en)
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
|
US7347850B2
(en)
|
1998-08-14 |
2008-03-25 |
Incept Llc |
Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6509327B1
(en)
|
1998-09-30 |
2003-01-21 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating otic, ophthalmic and nasal infections
|
|
CA2353642C
(fr)
|
1998-12-04 |
2009-11-10 |
Amarpreet S. Sawhney |
Polymeres reticules biocompatibles
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
DE60036236T2
(de)
|
1999-12-17 |
2008-05-21 |
Biopolymer Products Of Sweden Ab |
Neue bioadhäsive Zusammensetzung enthaltend ein bioadhäsives polyphenolisches Protein, ein Polymer mit Kohlenhydratgruppen, pharmazeutisch akzeptierbare feine Filamente und deren Verwendung
|
|
US20040175410A1
(en)
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6982090B2
(en)
|
2001-05-10 |
2006-01-03 |
Gillespie Donald E |
More easily visualized punctum plug configurations
|
|
TWI282271B
(en)
|
2002-09-18 |
2007-06-11 |
Allergan Inc |
Apparatus for delivery of ocular implants
|
|
US20050283109A1
(en)
|
2003-03-07 |
2005-12-22 |
Peyman Gholam A |
Method and apparatus for lacrimal canal obstruction
|
|
US20050197614A1
(en)
|
2004-03-04 |
2005-09-08 |
Wilson Pritchard |
Occlusive biomedical devices, punctum plugs, and methods of use thereof
|
|
US20050232972A1
(en)
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
BRPI0510485A
(pt)
*
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
WO2006002365A2
(fr)
|
2004-06-24 |
2006-01-05 |
Angiotech International Ag |
Microparticules fortement chargees en agent bioactif
|
|
CA2586177A1
(fr)
|
2004-11-02 |
2006-05-11 |
Pfizer Inc. |
Formes polymorphiques du 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole
|
|
EP1652552B1
(fr)
|
2004-11-02 |
2008-09-17 |
Sydney Biotech Pty. Ltd. |
Dispositif extraoculaire
|
|
US11129690B2
(en)
|
2006-03-28 |
2021-09-28 |
Devicor Medical Products, Inc. |
Method for making hydrogel markers
|
|
US8939910B2
(en)
|
2006-03-28 |
2015-01-27 |
Devicor Medical Products, Inc. |
Method for enhancing ultrasound visibility of hyperechoic materials
|
|
BRPI0709672B8
(pt)
|
2006-03-31 |
2021-06-22 |
3088922 Inc |
implante ocular insersível em um lúmen ocular e método de distribuição de um agente terapêutico a um olho
|
|
US8197435B2
(en)
|
2006-05-02 |
2012-06-12 |
Emory University |
Methods and devices for drug delivery to ocular tissue using microneedle
|
|
US9173773B2
(en)
|
2006-06-21 |
2015-11-03 |
Johnson & Johnson Vision Care, Inc. |
Punctal plugs for the delivery of active agents
|
|
AU2007294686B2
(en)
|
2006-09-15 |
2013-10-31 |
Equinox Sciences, Llc |
Kinase inhibitor compounds
|
|
US20080114076A1
(en)
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
|
US8080593B2
(en)
|
2006-11-29 |
2011-12-20 |
University Of Southern California |
Reversible thermoresponsive adhesives for implants
|
|
US8673286B2
(en)
|
2007-04-09 |
2014-03-18 |
Northwestern University |
DOPA-functionalized, branched, poly(aklylene oxide) adhesives
|
|
US20090227981A1
(en)
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
|
EP2134702B2
(fr)
|
2007-04-05 |
2023-08-30 |
Pfizer Products Inc. |
Formes cristallines de 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole utiles pour le traitement d'une croissance cellulaire anormale chez des mammiferes
|
|
US8231892B2
(en)
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
|
CA2750242C
(fr)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Delivrance de medicament par bouchons d'hydrogels
|
|
US20100247606A1
(en)
|
2009-03-25 |
2010-09-30 |
Allergan, Inc. |
Intraocular sustained release drug delivery systems and methods for treating ocular conditions
|
|
SG177761A1
(en)
|
2009-07-31 |
2012-03-29 |
Ascendis Pharma As |
Biodegradable polyethylene glycol based water-insoluble hydrogels
|
|
RU2558847C9
(ru)
|
2009-10-29 |
2016-07-20 |
Асцендис Фарма Ас |
Стерилизация биоразлагаемых гидрогелей
|
|
US9320647B2
(en)
|
2010-03-31 |
2016-04-26 |
Ocuject, Llc |
Device and method for intraocular drug delivery
|
|
US8821457B2
(en)
|
2010-09-08 |
2014-09-02 |
Johnson & Johnson Vision Care, Inc. |
Punctal plug containing drug formulation
|
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
|
US20130202587A1
(en)
|
2011-08-25 |
2013-08-08 |
Randox Laboratories Ltd. |
Identification of genetic variants
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
AU2012347926B2
(en)
|
2011-12-05 |
2018-03-15 |
Incept, Llc |
Medical organogel processes and compositions
|
|
CA2865132A1
(fr)
*
|
2012-02-22 |
2013-08-29 |
Trustees Of Tufts College |
Compositions et procedes pour administration oculaire d'un agent therapeutique
|
|
US11779682B2
(en)
|
2012-04-30 |
2023-10-10 |
The Johns Hopkins University |
Electro-mechanically stretched micro fibers and methods of use thereof
|
|
US10119202B2
(en)
|
2012-04-30 |
2018-11-06 |
The Johns Hopkins University |
Method for preparing electro-mechanically stretched hydrogel micro fibers
|
|
WO2013177367A2
(fr)
|
2012-05-23 |
2013-11-28 |
The Johns Hopkins University |
Composés et méthodes d'utilisation de ceux-ci pour traiter des troubles neurodégénératifs
|
|
MX2015005839A
(es)
|
2012-11-08 |
2015-12-17 |
Clearside Biomedical Inc |
Metodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
|
|
US10113033B2
(en)
|
2013-03-08 |
2018-10-30 |
Polyactiva Pty Ltd |
Polymer conjugate for delivery of a bioactive agent
|
|
SG11201507024VA
(en)
|
2013-03-08 |
2015-10-29 |
Polyactiva Pty Ltd |
Polymer conjugate for delivery of a bioactive agent
|
|
CA2908645A1
(fr)
|
2013-04-01 |
2014-10-09 |
Allergan, Inc. |
Dispositif d'administration de medicament par microsphere pour liberation intraoculaire prolongee
|
|
AU2014360184B2
(en)
|
2013-12-06 |
2020-07-23 |
Allergan, Inc |
Intracameral implant for treatment of an ocular condition
|
|
MX2016009312A
(es)
|
2014-01-16 |
2017-01-06 |
Ontogenesis Llc |
Composiciones y metodos para el tratamiento de la neovascularizacion y/o fuga intraocular.
|
|
HUE041469T2
(hu)
|
2014-02-04 |
2019-05-28 |
Pfizer |
PD-1 antagonista és VEGFR inhibitor kombinációja rák kezelésére
|
|
KR20150115533A
(ko)
*
|
2014-04-04 |
2015-10-14 |
씨제이제일제당 (주) |
1,5-디아미노펜탄의 정제방법
|
|
CN107205922A
(zh)
*
|
2014-12-10 |
2017-09-26 |
因赛普特有限责任公司 |
水凝胶药物递送植入物
|
|
WO2016178150A1
(fr)
|
2015-05-05 |
2016-11-10 |
Shilpa Medicare Limited |
Nouveaux polymorphes d'axitinib
|
|
EP3294212B1
(fr)
*
|
2015-05-12 |
2023-10-25 |
Incept, LLC |
Administration de médicament à partir d'hydrogels
|
|
MX2017015838A
(es)
|
2015-06-06 |
2018-08-15 |
Cloudbreak Therapeutics Llc |
Composiciones y metodos para tratar pterigion.
|
|
MY193229A
(en)
|
2015-06-16 |
2022-09-26 |
Merck Patent Gmbh |
Pd-l1 antagonist combination treatments
|
|
WO2017015616A1
(fr)
|
2015-07-22 |
2017-01-26 |
Envisia Therapeutics, Inc. |
Livraison de protéines dans l'oeil
|
|
KR20180034541A
(ko)
|
2015-07-22 |
2018-04-04 |
인셉트, 엘엘씨 |
코팅된 눈물점마개
|
|
US10420724B2
(en)
|
2015-11-25 |
2019-09-24 |
Incept, Llc |
Shape changing drug delivery devices and methods
|
|
BR112018074450A2
(pt)
|
2016-06-02 |
2019-03-19 |
Cloudbreak Therapeutics, Llc |
composições e métodos para a utilização de nintedanib para melhorar o sucesso da cirurgia do glaucoma
|
|
CN109982683A
(zh)
|
2016-09-23 |
2019-07-05 |
因赛普特有限责任公司 |
前房内药物递送储库
|
|
CN108884080B
(zh)
|
2016-09-29 |
2020-10-27 |
贝达药业股份有限公司 |
激酶抑制剂化合物的多晶型、含其的药物组合物及其制备方法和应用
|
|
CN110022794A
(zh)
|
2016-10-05 |
2019-07-16 |
泰坦医药品公司 |
具有减少的突释的用于药物递送的可植入装置
|
|
EP3638206A4
(fr)
|
2017-06-13 |
2020-12-02 |
EyePoint Pharmaceuticals, Inc. |
Dispositifs d'administration de médicaments bioérodable
|
|
KR20200131839A
(ko)
|
2018-03-16 |
2020-11-24 |
노파르티스 아게 |
안질환의 치료 방법
|
|
CA3132635A1
(fr)
|
2019-03-05 |
2020-09-10 |
Aerie Pharmaceuticals, Inc. |
Compositions pharmaceutiques pour le traitement de maladies ou de troubles oculaires
|
|
CN113939271A
(zh)
|
2019-04-25 |
2022-01-14 |
视觉治疗股份有限公司 |
眼用水凝胶酪氨酸激酶抑制剂植入物
|
|
AU2020283135A1
(en)
|
2019-05-31 |
2022-01-06 |
Dose Medical Corporation |
Bioerodible polyester polymer implants and related methods of use
|
|
HUE062928T2
(hu)
|
2020-03-25 |
2023-12-28 |
Ocular Therapeutix Inc |
Tirozin-kináz inhibitort tartalmazó szemészeti készítmény
|
|
US20220080044A1
(en)
|
2020-09-14 |
2022-03-17 |
National Yang-Ming University |
Method for preventing or treating peripheral arterial occlusive disease
|
|
MX2023004614A
(es)
*
|
2020-10-27 |
2023-05-09 |
Ocular Therapeutix Inc |
Implante ocular que contiene un agente activo.
|